7 .1.3 Dô on dinh
3.2. De xuât
- Tiép tue nghiên cuti nâng cô mê tù quy mô phông thi nghiêm lên quy mô lôn hon và dô on dinh cüa ché phâm dë hirông tôi âp dung trong sân xuât.
TÀI LIEU THAM KHÂO
Tài liêu tiê'ng viêt
1. Bô môn bào chë (2003), Sinh duoc hoc bào ché, Trucmg dai hoc duoc Hà Nôi, tr. 145-214.
2. Bô môn bào chê' (2004), Kÿ thuât bào ché và sinh duoc hoc câc dang thuoc tâp II, Nhà xuâ't ban Y hoc, tr. 40-100.
3. Bô môn duoc lÿ, Trucrng dai hoc Y khoa Hà nôi (1999), Duoc ly hoc,
Nhà xuâ't ban Y hoc, tr. 145-148.
4. Duoc diën Viêt nam III (2002), tr. 159-160. 5. Duoc thu quô'c gia Viêt nam (2002), tr. 638-642.
6. Chu Lê Mai (2006), Nghiên cùu bào chê' và dânh giâ khâ nâng hâp thu qua da cüa gel Lidocain, Luân van thac si duoc hoc, Trucmg dai hoc Duoc Hà Nôi.
7. Pham Thê' Manh (2002), Nghiên cûu ânh huông cüa acid oleic, l-menthol tôi khâ nâng giâi phông và hâp thu qua âa cüa Indomethacin, Khoa luân tôt nghiêp duoc si dai hoc, Trucmg dai hoc Duoc Hà Nôi.
8. Pham Thiêp, Vü Ngoc Thüy (1999), Thuoc biêt duoc và câch sü dung,
Nhà xuâ't bân Y hoc, tr. 499-500.
Tài liêu Tiê'ng Anh
9. Alvaro Jimenez-Kairuz et al (2002), “Mechanism of lidocaine release from carbomer-lidocaine hydrogels”, J. Pharm. Sci., 91, p. 267-272. 10. Barbara Gabriele Auner, Claudia Valenta (2004), “Influence of phloretin
on the skin permeation of lidocaine from semisolid préparations”, Eur. Pharm. Biopharm., 57, p. 307-312.
11.Brahma N. Singh et al (2005), “Effect of ionization and pénétration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum comeum”, Int. J. Pharm., 298, p. 98-107.
12. British Pharmacopoeia (2005), vol III, 2601-2604.
13. Chomchan Amnuaikit et al (2004), “Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use”, Int. J. Pharm., 289, p. 167-178.
14. Cristina Padula et al (2003), “Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior”, J. Controll. Rel., 88, p. 277-285.
15. E.J.Ricci et al (2005), “Sustained release of lidocaine from poloxamer 407 gels”, Int. J. Pharm., 288, p. 235-244.
16. E.J.Ricci et al (2002), “Rheological characterizition of poloxamer 407 lidocaine hydrochloride gels”, Eur. J. Pharm. Sci., 17, p. 161-167.
17. Gregory P. Kushla et al (1991), “Influence of pH on lidocaine pénétration through human and hairless mouse skin in vitro”, Int. J. P harm .,Il,p. 167-173.
18 .Handbook of pharmaceutical excipients (2005), The pharmaceutical Press, (CD)
19. Hirozaku Okamoto et al (2005), “Effect of sucrose fatty acid ester on transdermal permeation of lidocaine and ketoprofen”, Biol. Pharm. Bull.,
228, p. 1689-1694.
20. Katayoun Welin-Berger et al (2002), “Physicochemical interaction of local anesthetics with lipid model systems-correlation with in vitro permeation and in vivo efficacy”, J. Control. Rel., 81, p. 33-43.
21. M. Glavas- Dodov et al (2002), “Release profile of lidocaine HC1 from topical liposomal gel formulation”, Int. J. Pharm., 242, p. 381- 384.
22. Mel Yin Wang et al (2005), “Skin permeation of physotigmine from fatty acid based formulation, evaluating the choice of solvent”, Int. J. Pharm.,
209, p. 25- 36.
23. Martindale: the complété drug reference (2005), CD.
24. Mahmoud M. Soliman et al (2004), “Comparative clinical trial of topical anesthetic agent in cataract surgery”, /. Catar. Surg., 30, p. 1706-1720. 25. Pamela S. Davies, Bradley S. Galer (2004), “Review of lidocaine patch
5% studies in the treatment of postherpetic neuralgia”, Drugs 2004,
64(9), p. 937-947.
26. Philip J. Lee, Naina Ahmad, Robert Langer (2006), “Evaluation of chemical enhancers in the transdermal delivery of lidocaine”, Int. J. Pharm., 306, p. 33-39.
27. Rakan Matsui et al (2005), “Skin permeation of lidocaine from crystal suspended oily formulations”, DrugDev. Ind. Pharm., 31, p. 729-738. 28. Sang-Chul Shin et al (2004), “Development of lidocaine gels for
enhanced local anesthetic action”, Int. J. Pharm., 287, p. 73-78.
29. Sang- Chul Shin et al (2003), “Préparation and évaluation of bioadhesive benzocaine gel for enhanced local anesthetic effects”, Int. J. Pharm.,
260, p. 77-81.
30. The Pharmaceutical Codex (1994), p. 937-940.
31. United State Pharmacopoeia 29 (2005), II, p. 1251- 1255.
32. Zhijian Wu et al (2005), “Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels”, Int. J. Pharm., 104, p. 497- 505.